Recombinant ICOS (Feladilimab Biosimilar) antibody

Catalog No. ABIN7597687

The Humanized Chimeric anti-ICOS (Feladilimab Biosimilar) antibody is suitable to detect ICOS (Feladilimab Biosimilar) in samples from Human.

Quick Overview for Recombinant ICOS (Feladilimab Biosimilar) antibody (ABIN7597687)

Target: ICOS (Feladilimab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Humanized

Clonality: Chimeric

Conjugate: This ICOS (Feladilimab Biosimilar) antibody is un-conjugated

Application: Please inquire

Grade: Research Grade

Product Details anti-ICOS (Feladilimab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Research Grade Feladilimab Biosimilar Antibody

Specificity: CD278, ICOS, Inducible T-cell costimulator, Activation-inducible lymphocyte immunomediatory molecule, AILIM

Purification: Protein A or G purified from cell culture supernatant.

Purity: >95 % by SDS-PAGE.

Isotype: IgG4 kappa

Application Details

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1 mg/mL

Buffer: 0.01M PBS, pH 7.4.

Storage: 4 °C,-20 °C,-80 °C

Storage Comment: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.

Expiry Date: 12 months

Target Details for ICOS (Feladilimab Biosimilar)

Target: ICOS (Feladilimab Biosimilar)

Alternative Name: Feladilimab Biosimilar

Target Type: Biosimilar

Background: CD278, ICOS, Inducible T-cell costimulator, Activation-inducible lymphocyte immunomediatory molecule, AILIM

UniProt: Q9Y6W8

CAS-No: 2252518-85-5